Atypical experience: A case series of pediatric aripiprazole exposures

Journal of Toxicology - Clinical Toxicology

Volumn 43, Issue 3, 2005, Pages 151-153

  Lofton, Amenda L ^a   Klein Schwartz, Wendy ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Aripiprazole; Overdose; Pediatric; Toxicity

Indexed keywords

ARIPIPRAZOLE; DIPHENHYDRAMINE; ACTIVATED CARBON; ATOMOXETINE;

ADOLESCENT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFECT; DRUG INTOXICATION; DRUG OVERDOSE; FACE MUSCLE; FEMALE; FLACCID PARALYSIS; GASTROINTESTINAL DISEASE; HUMAN; LETHARGY; MALE; SUICIDE; SYMPTOM; VOMITING; HYPERSALIVATION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; OVERDOSE; PEDIATRICS; PIPERAZINES; POISON CONTROL CENTERS; QUINOLONES; SUICIDE, ATTEMPTED; TREATMENT OUTCOME;

EID: 18744362453     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-200053095     Document Type: Article

References (10)

1. Stahl SM. Dopamine system stabilizers, aripiprazole and the next generation of antipsychotics, part 2. J Clin Psychiatry 2001; 62:923-924.
2. Taylor DM. Aripiprazole: a review of its pharmacology and clinical use. Int J Clin Prac 2003; 57:49-54.
3. Freedman R. Schizophrenia. N Eng J Med 2003; 349(18):1738-1749.
4. Marder SR, McQuade RD, Stock E, Kaplita S, Marcus R, Safferman A, Saha A, Ali M, Iwamoto T. Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials. Schizophrenia Res 2003; 61(2-3):123-136.
5. Abilify® (Aripiprazole) [Product Information]. Bristol-Myers Squibb: Princeton, NJ, 2003.
6. Seifert SA. Aripiprazole (Abilify®) overdose in a 2.5 year old [abstract]. J Toxicol Clin Toxicol 2003; 41(5):647-648.
7. Davenport JD, McCarthy MW, Buck ML. Excessive somnolence from aripiprazole in a child. Pharmacotherapy 2004; 24(4):522-525.
8. Schaeffer JL, Ross RG. Childhood-onset schizophrenia: premorbid and prodromal diagnostic and treatment histories. J Am Acad Child Adolesc Psychiatry 2002; 41:538-545.
9. Olfson M, Marcus SC, Weissman MM, Jensen PS. National trends in the use of psychotropic medications in children. J Am Acad Child Adolesc Psychiatry 2002; 41:514-521.
10. Blumer JL, Findling R, Kauffman R. Pharmacokinetics, tolerability and safety of aripiprazole in children and adolescents with conduct disorder [abstract]. Clin Pharmacol Ther 2002; 71:P5.